Growing up milk and recurrent upper respiratory infections in children

The influence of young child formula with added short-chain galactoolichosaccharides, long-chain fructooligosaccharides and n-3 long chain polyunsaturated fatty acids on recurrent upper respiratory tract infections in children: a randomised, controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24246

Enrollment

140

Registered

2016-06-03

Start date

2015-06-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children aged 12-36 months with recurrent upper respiratory tract infections

Interventions

young child formula with added short-chain galactoolichosaccharides, long-chain fructooligosaccharides and n-3 long chain polyunsaturated fatty acids

Eligibility

Inclusion criteria

Inclusion criteria: age 12-36 months recurrent upper respiratory tract infections (>1 a month in the last 3 months) familiar with cow milk drinking understanding dutch language written informed consent

Exclusion criteria

Exclusion criteria: cow milk allergy, lactose intolerant, fish protein allergy immunological deficiencies atopic dermatitis prophylactic use of antibiotics disorders requiring a special diet a known disorder on intestinal absorption current use of follow up milk chromosomal disorders

Design outcomes

Primary

Measure	Time frame
decrease number of days a month with upper respiratory tract infection	—

Secondary

Measure	Time frame
laboratory parameters; immunoglobulins, hemoglobulin, vitamins	—

Contacts

Public ContactT.Z. Hummel

MST, Enschede

EnschedeT.Hummel@mst.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)